Durable biochemical response and safety with oral octreotide capsules in acromegaly.
Saved in:
| Title: | Durable biochemical response and safety with oral octreotide capsules in acromegaly. |
|---|---|
| Authors: | Samson SL; Department of Medicine and Neurological Surgery, Mayo Clinic, Jacksonville, Florida, USA., Nachtigall LB; Neuroendocrine Unit, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Fleseriu M; Pituitary Center, Oregon Health & Sciences University, Portland, Oregon, USA., Jensterle M; University Medical Centre Ljubljana, Ljubljana, Slovenia., Manning PJ; Dunedin Hospital, Dunedin, New Zealand., Elenkova A; Department of Endocrinology, Medical University Sofia, USHATE 'Acad. Ivan Penchev', Sofia, Bulgaria., Molitch ME; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Ludlam WH; Amryt Pharmaceuticals, Dublin, Ireland.; Recordati Rare Diseases, Lebanon, New Jersey, USA., Patou G; Amryt Pharmaceuticals, Dublin, Ireland., Haviv A; Amryt Pharmaceuticals, Dublin, Ireland., Biermasz NR; Leiden University Medical Center, Leiden, Netherlands., Giustina A; Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University, Milan, Italy., Strasburger CJ; Clinical Endocrinology, Charite-Universitätsmedizin, Campus Mitte, Berlin, Germany., Kennedy L; Cleveland Clinic Foundation, Cleveland, Ohio, USA., Melmed S; Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, California, USA. |
| Source: | European journal of endocrinology [Eur J Endocrinol] 2022 Oct 26; Vol. 187 (6), pp. 733-741. Date of Electronic Publication: 2022 Oct 26 (Print Publication: 2022). |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
